Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.

Carl ErikssonSara RundquistVyron LykiardopoulosRuzan UdumyanPer KarlénOlof GripCharlotte SödermanSven AlmerErik HertervigJan MarsalJenny GunnarssonCarolina MalmgrenJenny DelinHans StridMats SjöbergDavid ÖbergDaniel BergemalmHenrik HjortswangJonas Halfvarsonnull null

Published in: Therapeutic advances in gastroenterology (2021)

Vedolizumab proved effective for the treatment of refractory IBD in clinical practice.

Keyphrases

ulcerative colitis
clinical practice
patients with inflammatory bowel disease
randomized controlled trial
systematic review
clinical trial
study protocol
cross sectional
double blind
combination therapy
smoking cessation